A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CLSI / Clinical and Laboratory Standards Institute

[Related PubMed/MEDLINE]
Total Number of Papers: 1365
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CLSI  (>> Co-occurring Abbreviation)
Long Form:   Clinical and Laboratory Standards Institute
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A comparative genomic analysis of small-colony variant and wild-type Burkholderia pseudomallei in a patient with bacterial liver abscess. B. pseudomallei, MLST, SCV, WT
2020 A continued method performance monitoring approach for the determination of pediatric renin samples - application within a European clinical trial. LENA, QC
2020 A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of "Bad Bugs, Few Drugs". ESBL, EUCAST, PK/PD, STIC, uLUTIs, USCAST
2020 A Dimer, but Not Monomer, of Tobramycin Potentiates Ceftolozane against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa and Delays Resistance Development. MDR, XDR
2020 A preliminary study for the establishment of a reference interval for vitamin B12 in China after performance verification of a second-generation ECLIA kit. ECLIA, RI
2020 Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018). CBPs, ECVs, HS, non-WT
2020 An updated protocol based on CLSI document C37 for preparation of off-the-clot serum from individual units for use alone or to prepare commutable pooled serum reference materials. ---
2020 Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics. ARDS, rRT-PCR
2020 Antibiotic resistance patterns and prevalence of class I, II and III Integrons among clinical isolates of Klebsiella pneumoniae. MDR, PCR
10  2020 Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018. FDA, NDM
11  2020 Antibiotic susceptibility variations of Methicillin-resistant Staphylococcus aureus after gamma irradiation. MHA, OX
12  2020 Antifungal Susceptibility of Clinical Isolates and Artificially Produced Multi-azole-resistant Strains of Cryptococcus neoformans (formerly: Cryptococcus grubii) to Ravuconazole. FLCZ, RVCZ
13  2020 Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015-2017). BHS, MRSA, VGS
14  2020 Antimicrobial Resistance of Staphylococcus aureus Isolated from Hospital Wastewater in Kermanshah, Iran. AR, ARGs, MDR, MRSA, MSSA
15  2020 Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART). ETP-NS-non-CPE, IAI, MICs, PK/PD, SMART
16  2020 Antimicrobial susceptibility monitoring of canine and feline skin and ear pathogens isolated from European veterinary clinics: results of the ComPath Surveillance programme. CoNS, MIC
17  2020 Antimicrobial Susceptibility Pattern of Porcine Respiratory Bacteria in Spain. APP, MIC, PM
18  2020 Assessment of mortality stratified by meropenem minimum inhibitory concentration in patients with Enterobacteriaceae bacteraemia: A patient-level analysis of published data. ---
19  2020 Assignment of international normalized ratio to frozen and freeze-dried pooled plasmas. INR, ISI, SSC/ISTH
20  2020 Azole antifungal resistance in fungal isolates from wastewater treatment plant effluents. FCZ, ITZ, KTZ, VCZ, WWTPs
21  2020 Biocide susceptibility testing of bacteria: Development of a broth microdilution method. BST, DCS, MICs, SC
22  2020 CALIPER paediatric reference intervals for the urea creatinine ratio in healthy children & adolescents. CALIPER, RIs, UCR
23  2020 Candida auris: Clinical profile, diagnostic challenge and susceptibility pattern: Experience from a tertiary-care centre in South India. AFST, ITS
24  2020 Carba NP test for the detection of carbapenemase-producing Pseudomonas aeruginosa. ---
25  2020 Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. CA, CRE, HA, MHT
26  2020 Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt. CPs, CR, GNB, MDR, XDR
27  2020 Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-negative Bacilli: A Comparison of Disk Diffusion to Broth Microdilution. AST, BMD, BPs, CA, CRE, DD, EUCAST, FDA, GNB, ME, mE, RUO, VME
28  2020 Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) position statements on polymyxin B and colistin clinical breakpoints. EUCAST, MICs, PD, PK
29  2020 Community based reference interval of selected clinical chemistry parameters among apparently healthy Adolescents in Mekelle City, Tigrai, Northern Ethiopia. ALB, ALP, AST, FBS, IFCC, RIs
30  2020 Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical andLaboratory Standards Institute and International Federation of Clinical Chemistry approaches. CCMs, EQA, HWBs, IFCC, PHSs, POC
31  2020 Comparative Evaluation of MIRONAUT-AM and CLSI broth microdilution method for antifungal susceptibility testing of Aspergillus species against four commonly used antifungals. non-WT
32  2020 Comparative Routine Therapeutic Drug Monitoring of Mycophenolic Acid in human Plasma with HPLC-UV and Isotope Dilution LC-MS/MS. HPLC-UV, MPA, TDM
33  2020 Comparison of Agar Dilution to Broth Microdilution for Testing in vitro Activity of Cefiderocol against Gram-negative Bacilli. AD, BMD, CA, CFDC, EA, ID-BMD, MIC
34  2020 Comparison of in vitro activities of 11 antifungal agents against Trichophyton verrucosum isolates associated with a variety hosts and geographical origin. ---
35  2020 Daptomycin Susceptibility of Group B Streptococcus. GBS, MIC
36  2020 Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters. DCT, EKP, MICs
37  2020 Determination of the cut-off prothrombin time to estimate plasma rivaroxaban overdose status. INR, PT, RIV, ROC
38  2020 Development and evaluation of an element-tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection: can we apply the new assay in the clinical laboratory? CEA, ECLIA, ICP-MS
39  2020 Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute. SDD
40  2020 Drug susceptibility testing of Mycobacterium simiae: An emerging pathogen in Iran. DST
41  2020 EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-beta-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations. eCIM, MBL, mCIM
42  2020 Effect of Cinnamomum verum leaf essential oil on virulence factors of Candida species and determination of the in-vivo toxicity with Galleria mellonella model. EO, GC-MS, MIC, SEM
43  2020 Efficacy of Antimicrobials Against Multidrug-Resistant Acinetobacter baumannii from Patients in a Tertiary Care Hospital. API, MDR
44  2020 Efficient Synthesis and Antibacterial Profile of Bis(2-hydroxynaphthalene- 1,4-dione). ADMET, MIC, MRSA
45  2020 Emergence of a multidrug-resistant hypervirulent Pasteurella multocida ST342 strain with a floR-carrying plasmid. CARD, MICs, ST342
46  2020 Emergence of vanA-Type Vancomycin-Resistant Enterococcus faecium ST 78 Strain with a rep2-Type Plasmid Carrying a Tn1546-Like Element Isolated from a Urinary Tract Infection in China. MLST, ST, VRE
47  2020 Epidemiological analysis of Group A Streptococcus infections in a hospital in Beijing, China. GAS
48  2020 Estimation of reference intervals of insulin resistance (HOMA), insulin sensitivity (Matsuda), and insulin secretion sensitivity indices (ISSI-2) in Polish young people. ---
49  2020 Evaluating sample stability in the clinical laboratory with the help of linear and non-linear regression analysis. ANOVA
50  2020 Evaluation of an Ion-Exchange HPLC Device for HbA1c Measurement. ---
51  2020 Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of beta-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens. ESBL, EUCAST, KPC, MBL
52  2020 Evaluation of disc diffusion tests and agar screening for predicting mecA-mediated oxacillin resistance in Staphylococcus lugdunensis revealed a cefoxitin-susceptible, mecA-positive S. lugdunensis clonal complex 27 clone. CA, ME, MRSA, PBP2a, S. lugdunensis, VME
53  2020 Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation. CFR, CRE, EUCAST, IVFOS, MCS, MIC, PTA
54  2020 Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species. CAs, ECV, SYO, YS08
55  2020 Expert Opinion on Verification of Antimicrobial Susceptibility Tests. AST
56  2020 Extended-Spectrum beta-lactamase-Producing Enterobacteriaceae Shedding in Farm Horses Versus Hospitalized Horses: Prevalence and Risk Factors. ESBL, OR, PCR
57  2020 External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international survey. AAPs, EQA, IFCC C-MD, ISO, LDT, QC, SOPs
58  2020 First report of mecC gene in clinical methicillin resistant S. aureus (MRSA) from tertiary care hospital Islamabad, Pakistan. MICs, MLST, MRSA, MSSA, PFGE, S. aureus
59  2020 From CLSI to EUCAST, a necessary step in Spanish laboratories. EUCAST
60  2020 Fungal profile and antifungal susceptibility pattern in patients with oral candidiasis. AmB, FLC, GM, KTC, MIC, NYT, SDA, VRC
61  2020 Haematological and biochemical reference intervals in healthy racing and retired Italian Greyhounds. CHCM, LUC, MCH, MCHC, RBC, RIs
62  2020 Identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Testing of Non-Aspergillus Molds. COV, EA, MALDI-TOF MS, MICs
63  2020 Importance of Susceptibility Rate of 'the First' Isolate: Evidence of Real-World Data. FI, TI
64  2020 Improving equivalence in fibrinogen evaluation between the prothrombin time-derived fibrinogen assay and Clauss method using a pooled plasma calibrator. FIB, PT-Fib
65  2020 Improving the reproducibility, accuracy, and stability of an electrochemical biosensor platform for point-of-care use. CTCs, POC, SMT
66  2020 In vitro Activity of a New Fourth-Generation Cephalosporin, Cefoselis, Against Clinically Important Bacterial Pathogens in China. ESBL, MICs, MRSA, MSSA
67  2020 In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units. ---
68  2020 In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum beta-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016). ESBL
69  2020 In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli. EUCAST
70  2020 In vitro anti-Pythium insidiosum activity of amorolfine hydrochloride and azithromycin, alone and in combination. AMR, AZM, MIC
71  2020 Increasing Prevalence of Multidrug-Resistant Candida haemulonii Species Complex among All Yeast Cultures Collected by a Reference Laboratory over the Past 11 Years. ITS
72  2020 Is it time to move away from polymyxins?: evidence and alternatives. MDR, XDR
73  2020 Is There Emergence of beta-Lactam Antibiotic-Resistant Streptococcus pyogenes in China? ---
74  2020 Isolation of Acinetobacter species from Clinical Specimens with Detection of Their Antimicrobial Susceptibility Pattern from a Tertiary Care Hospital, Bangladesh. ---
75  2020 Minimum Inhibitory Concentrations of Vancomycin and Daptomycin Against Methicillin-resistant Staphylococcus Aureus Isolated from Various Clinical Specimens: A Study from South India. E-test, MICs, S. aureus, VISA, VRSA
76  2020 Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex. ECVs
77  2020 Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China. GAS, PCR, SAg
78  2020 Molecular Epidemiology of Myroides odoratimimus in Nosocomial Catheter-Related Infection at a General Hospital in China. CRI, MALDI-TOF MS, PCR, PFGE
79  2020 Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex. BMD, CA, EA, EUCAST, FDA, ISO, MEs, P/T
80  2020 Multicenter evaluation of the RAPIDEC CARBA NP assay for the detection of carbapenemase production in clinical isolates of Enterobacterales and Pseudomonas aeruginosa. NPA, PPA
81  2020 Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal. ESBL, IQR, MDR, UTI
82  2020 Newborn Screening Practices and Alpha-Thalassemia Detection - United States, 2016. Hb
83  2020 Non-typhoidal Salmonella infections among children in a tertiary hospital in Ningbo, Zhejiang, China, 2012-2019. iNTS, non-iNTS, NTS
84  2020 Novel mutations in the resistome of a new sequence type (ST262) of clarithromycin resistant Mycobacterium abscessus subsp. massiliense. MLST, ST
85  2020 Pathogen identification in 84 Patients with post-traumatic osteomyelitis after limb fractures. PTO
86  2020 Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates. EUCAST
87  2020 Pharmacokinetics of levofloxacin after single intravenous and oral administration, and its interaction with sucralfate in mixed-breed dogs. HPLC
88  2020 Phenotypic and Genotypic Correlates of Penicillin Susceptibility in Nontoxigenic Corynebacterium diphtheriae, British Columbia, Canada, 2015-2018. ---
89  2020 Phenotypic antimicrobial resistance in Escherichia coli strains isolated from swine husbandries in North Western Germany - temporal patterns in samples from laboratory practice from 2006 to 2017. E. coli
90  2020 Plasmid-Mediated Quinolone Resistance in Pseudomonas aeruginosa Isolated from Burn Patients in Tehran, Iran. rep-PCR
91  2020 Population pharmacokinetics of anidulafungin in ICU patients assessing inter- and intrasubject variability. BMI, CL, ICUs, IOV, PK, PTA, SOFA
92  2020 Prevalence and Antifungal Susceptibility of Pathogenic Yeasts in China: A 10-Year Retrospective Study in a Teaching Hospital. MALDI-TOF MS, MICs
93  2020 Prevalence of Multi-Antibiotic Resistant Escherichia coli and Klebsiella species obtained from a Tertiary Medical Institution in Oyo State, Nigeria. MAR
94  2020 Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. NAC, VVC
95  2020 Putative Protein Biomarkers of Escherichia coli Antibiotic Multiresistance Identified by MALDI Mass Spectrometry. MS
96  2020 Rapid Detection of Echinocandins Resistance by MALDI-TOF MS in Candida parapsilosis Complex. CCI, MALDI-TOF
97  2020 Rapid Emergence of a Pandrug-Resistant Klebsiella pneumoniae ST11 Isolate in an Inpatient in a Teaching Hospital in China After Treatment with Multiple Broad-Spectrum Antibiotics. ESBL, ICU
98  2020 Rapid inductively coupled plasma mass spectrometry method to determine iodine in amniotic fluid, breast milk and cerebrospinal fluid. AFIC, BMIC, CSF, ICP-MS, LOD, LOQ, PUMCH
99  2020 Rare Invasive Yeast Infections in Greek Neonates and Children, a Retrospective 12-Year Study. IFI
100  2020 Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin. AST, AZI, CRO, ECV, FDA